Patient Newsletter – January 2023

January 2023

Inside this edition, we will be covering the following topics:

  • 2023 & What we have planned so far
  • Legs Out for Lymphoma
  • Our partnership with Dermal Therapy
  • Patient Treatment Support Kit
  • Welcome to our New Nurses
  • Sex, Intimacy & Sexual Health
  • EOI – Languages other than English
  • Latest PBS submissions
  • ALLG
  • Upcoming Support Groups 
  • Caryl’s Coaching
  • Nurse Support Line 1800 953 081 
Image of Lymphoma Australia morning tea in QLD with patients, carers and Lymphoma Australia staff.

Click here to read the January 2023 Patient Newsletter

Share This

Contact Lymphoma Australia Today!

Please note: Lymphoma Australia staff are only able to reply to emails sent in English language.

For people living in Australia, we can offer a phone translation service. Have your nurse or English speaking relative call us to arrange this.

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.